NYSE
RXO
Last Price
US $27.74
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
RXO, Inc. cash flow to debt ratio of 5.92% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
RXO, Inc.'s free cash flow has increased -85.96% from $-57.00M last year to $-8.00M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
RXO, Inc.'s debt to equity ratio is 0.46, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
RXO, Inc.'s debt has increased relative to shareholder equity from 0.41 last year to 0.46 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
RXO, Inc. has a net debt to EBITDA ratio of 23.42x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial risk - ICR.
RXO, Inc.'s interest coverage ratio is -1.00, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
RXO, Inc.'s profit margin has increased (-71.27%) in the last year from -6.37% to -1.83%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
RXO, Inc.'s short-term assets of $1.32G exceed its short-term liabilities of $1.04G
Decreasing performance - ROA.
RXO, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
RXO, Inc.'s return on equity of -6.75%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
RXO, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
RXO, Inc. had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
RXO, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
RXO, Inc. has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
RXO, Inc.'s yearly earnings has increased -65.52% since last year from $-290.00M to $-100.00M, signaling increasing performance
Increasing performance - Healthy revenue growth.
RXO, Inc.'s yearly revenue has increased 26.20% since last year from $4.55G to $5.74G, signaling increasing performance
Decreasing performance - ROIC.
ROIC -0.95% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
RXO, Inc.'s 3-year revenue CAGR of 6.18% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
RXO, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
RXO, Inc. had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
RXO, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
RXO, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
RXO, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
RXO, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
RXO, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
RXO, Inc. has a price-to-book ratio of 3.04x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
RXO, Inc. has a price-to-sales ratio of 0.78x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-6.75%
Return on equity
ROIC: -0.95%
Valuation History
-44X
Price to Earnings
EV/EBITDA: -245.4X
Cash flow
Profit margin
-23.00%
(FY vs FY)
Cash flow Y/Y
22.42%
(FY vs FY)
Fair Value
Market $27.74
-76.50%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.